doi: 10.1016/S2213-8587(22)00387-4 Summary Keywords type 2 diabetes, children, SGLT2 inhibitors, empagliflozin, hyperglycemia Citation Castorani V, Chiarle E, Savastio S, Pozzi E, Partenope C, Pignatiello C, Dimarakis S, Demichelis M, Medina F and Rabbone I (2025) Established and emerging use of sodium-glucose cotransporter-2 inhibitors in pediatric population with type 2 diabetes: a case report and literature review
PubMed Jensen, L., Helleberg, H., Roffel, A., van Lier, J.J.,Bjrnsdottir, I., Pedersen, P.J., Rowe, E., Derving Karsbl, J., & Pedersen, M.L
Retatrutide peptide is an investigational incretin-based metabolic drug being studied for obesity, type 2 diabetes, and related cardiometabolic conditions
1 A ) could shape excitatory transmission, we measured the frequency of miniature excitatory postsynaptic currents (mEPSCs), a reflection of presynaptic drive
Exposure to high temperatures (above the recommended limits) can cause the protein structure to denature or break down, reducing the medication's potency